BMP-655/ACS+Standard of care or Standard of care + BMP-655/ACS+Standard of care or Standard of care + BMP-655/ACS+Standard of care or Standard of care
Phase 1Terminated 0 watching 0 views this week💤 Quiet
32
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Rotator Cuff Tear
Conditions
Rotator Cuff Tear
Trial Timeline
Jun 1, 2010 → Apr 1, 2012
NCT ID
NCT01122498About BMP-655/ACS+Standard of care or Standard of care + BMP-655/ACS+Standard of care or Standard of care + BMP-655/ACS+Standard of care or Standard of care
BMP-655/ACS+Standard of care or Standard of care + BMP-655/ACS+Standard of care or Standard of care + BMP-655/ACS+Standard of care or Standard of care is a phase 1 stage product being developed by Pfizer for Rotator Cuff Tear. The current trial status is terminated. This product is registered under clinical trial identifier NCT01122498. Target conditions include Rotator Cuff Tear.
Hype Score Breakdown
Clinical
10
Activity
5
Company
9
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01122498 | Phase 1 | Terminated |
Competing Products
5 competing products in Rotator Cuff Tear
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Secukinumab + Placebo | Novartis | Phase 3 | 77 |
| Secukinumab + Placebo | Novartis | Phase 3 | 77 |
| BMP-655/ACS or Standard of Care + BMP-655/ACS or Standard of Care + BMP-655/ACS or Standard of Care | Pfizer | Phase 1 | 32 |
| Pregabalin | Viatris | Approved | 82 |
| Single Injection of Local Anesthetic | Baxter | Phase 1 | 30 |